Objective: The loss of driving privileges in glaucoma patients has a significant impact on personal, social, and economic well-being. As a result, glaucoma patients are believed to highly value any intervention or pharmaceutical agent that can either preserve or extend visual acuity. The objective of this study was to assess the willingness to pay to maintain driving privileges in patients with glaucoma. Methods: A mailed survey assessing glaucoma severity, current driving status and willingness to pay for additional years of driving privileges was sent to a random sample of 5,000 individuals. A contingent valuation scenario was posed to individuals as “Your physician tells you that there is a treatment available for glaucoma that will increase your chances to see for a longer period of time, and thus maintain your ability to drive independently. However, the treatment is not covered by your insurer. If you had to make a decision today, what is the maximum amount you would be willing to pay for the treatment in order to maintain driving privileges for one more year?” Results: A total of 2,009 individuals completed the survey for a 40% response rate. The majority of the responders were women (70%) and the mean age of the population was 60.5 (SD=16.5) years. Over 60% of individuals rated their glaucoma as mild and 73% of individuals reported that they still drive. Approximately 43% of responders replied that they would pay up to $50,000 for one additional year of driving privileges. Conclusion: Driving privileges and personal independence are highly valued by older individuals. In order to maintain their driving privileges and personal independence, older individuals are willing to pay a substantial amount of money to improve visual acuity.